Skip to main content

Table 2 Comparison of CMR parameters

From: Relationship between native papillary muscle T1 time and severity of functional mitral regurgitation in patients with non-ischemic dilated cardiomyopathy

 

DCM MR (+), N = 22

DCM MR (-), N = 18

Controls, N = 20

* P-value

DCM MR (+) vs DCM MR (-)

* P-value

DCM MR (+) vs Controls

* P-value

DCM MR (-) vs Controls

Cine MRI parameters

 EDVI, mL/m2

129 ± 43

122 ± 36

80 ± 16

0.79

<0.05

<0.05

 ESVI. mL/m2

89 ± 43

84 ± 36

32 ± 10

0.86

<0.05

<0.05

 SVI, mL/m2

40 ± 11

38 ± 10

48 ± 10

0.86

0.04

0.02

 LVEF, %

34 ± 13

33 ± 11

61 ± 4

0.98

<0.05

<0.05

 LVMI, g/m2

67 ± 23

68 ± 17

46 ± 9

0.99

<0.05

<0.05

 RVEF, %

52 ± 10

52 ± 14

58 ± 5

1.00

0.15

0.18

 LA dimension, mm

58 ± 9

55 ± 7

52 ± 9

0.59

0.06

0.41

 LA area (2 chamber view), cm2

29 ± 9

25 ± 6

-

0.21

-

-

 LA area (4 chamber view), cm2

28 ± 9

23 ± 6

-

0.07

-

-

 LA volume (ml)

125 ± 54

92 ± 31

-

0.04

  

 RA dimension, mm

51 ± 10

52 ± 9

55 ± 9

0.98

0.42

0.58

LGE findings

 LV LGE

3 (15 %)

5 (27 %)

0 (0 %)

0.27

0.09

0.01

 Papillary muscle LGE

0 (0 %)

0 (0 %)

0 (0 %)

-

-

-

  1. *P value was calculated by one-way ANOVA with Tukey’s correction or Chi-square test
  2. ANOVA analysis of variance, CMR cardiovascular magnetic resonance, DBP diastolic blood pressure, DCM dilated cardiomyopathy, EDV end-diastolic volume, EDVI end-diastolic volume index, EF ejection fraction, ESV end-systolic volume, ESVI end-systolic volume index, HR heart rate, LGE late gadolinium enhancement, LV left ventricle, LVMI left ventricular mass index, MR mitral regurgitation